REZOLUTE INC (RZLT) Stock Fundamental Analysis

NASDAQ:RZLT • US76200L3096

3.175 USD
-0.12 (-3.5%)
Last: Feb 27, 2026, 11:40 AM
Fundamental Rating

3

We assign a fundamental rating of 3 out of 10 to RZLT. RZLT was compared to 521 industry peers in the Biotechnology industry. No worries on liquidiy or solvency for RZLT as it has an excellent financial health rating, but there are worries on the profitability. RZLT does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

1

1. Profitability

1.1 Basic Checks

  • In the past year RZLT has reported negative net income.
  • RZLT had a negative operating cash flow in the past year.
  • RZLT had negative earnings in each of the past 5 years.
  • RZLT had a negative operating cash flow in each of the past 5 years.
RZLT Yearly Net Income VS EBIT VS OCF VS FCFRZLT Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 -20M -40M -60M

1.2 Ratios

  • The Return On Assets of RZLT (-60.76%) is comparable to the rest of the industry.
  • RZLT's Return On Equity of -65.80% is in line compared to the rest of the industry. RZLT outperforms 58.16% of its industry peers.
Industry RankSector Rank
ROA -60.76%
ROE -65.8%
ROIC N/A
ROA(3y)-45.28%
ROA(5y)-42.37%
ROE(3y)-49.01%
ROE(5y)-50.92%
ROIC(3y)N/A
ROIC(5y)N/A
RZLT Yearly ROA, ROE, ROICRZLT Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 2K 4K 6K

1.3 Margins

  • RZLT does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
RZLT Yearly Profit, Operating, Gross MarginsRZLT Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025

8

2. Health

2.1 Basic Checks

  • RZLT has more shares outstanding than it did 1 year ago.
  • The number of shares outstanding for RZLT has been increased compared to 5 years ago.
  • RZLT has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
RZLT Yearly Shares OutstandingRZLT Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M 80M
RZLT Yearly Total Debt VS Total AssetsRZLT Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M

2.2 Solvency

  • RZLT has an Altman-Z score of 11.67. This indicates that RZLT is financially healthy and has little risk of bankruptcy at the moment.
  • RZLT has a Altman-Z score of 11.67. This is amongst the best in the industry. RZLT outperforms 83.30% of its industry peers.
  • RZLT has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 11.67
ROIC/WACCN/A
WACCN/A
RZLT Yearly LT Debt VS Equity VS FCFRZLT Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 50M -50M 100M 150M

2.3 Liquidity

  • A Current Ratio of 14.18 indicates that RZLT has no problem at all paying its short term obligations.
  • RZLT has a Current ratio of 14.18. This is amongst the best in the industry. RZLT outperforms 90.59% of its industry peers.
  • RZLT has a Quick Ratio of 14.18. This indicates that RZLT is financially healthy and has no problem in meeting its short term obligations.
  • Looking at the Quick ratio, with a value of 14.18, RZLT belongs to the top of the industry, outperforming 90.59% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 14.18
Quick Ratio 14.18
RZLT Yearly Current Assets VS Current LiabilitesRZLT Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M

1

3. Growth

3.1 Past

  • RZLT shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 23.77%, which is quite impressive.
EPS 1Y (TTM)23.77%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%0%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

  • Based on estimates for the next years, RZLT will show a very strong growth in Earnings Per Share. The EPS will grow by 26.81% on average per year.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y26.39%
EPS Next 2Y13.68%
EPS Next 3Y18.24%
EPS Next 5Y26.81%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
RZLT Yearly Revenue VS EstimatesRZLT Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2027 2028 2029 2030 2031 2032 2033 100M 200M 300M 400M 500M
RZLT Yearly EPS VS EstimatesRZLT Yearly EPS VS EstimatesYearly EPS VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033 0 -5 -10 -15

0

4. Valuation

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for RZLT. In the last year negative earnings were reported.
  • Also next year RZLT is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
RZLT Price Earnings VS Forward Price EarningsRZLT Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
RZLT Per share dataRZLT EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 -0.5 1

4.3 Compensation for Growth

  • A more expensive valuation may be justified as RZLT's earnings are expected to grow with 18.24% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y13.68%
EPS Next 3Y18.24%

0

5. Dividend

5.1 Amount

  • No dividends for RZLT!.
Industry RankSector Rank
Dividend Yield 0%

REZOLUTE INC

NASDAQ:RZLT (2/27/2026, 11:40:39 AM)

3.175

-0.12 (-3.5%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Earnings (Last)02-12
Earnings (Next)05-11
Inst Owners109.4%
Inst Owner Change0.51%
Ins Owners1.52%
Ins Owner Change0.78%
Market Cap294.42M
Revenue(TTM)N/A
Net Income(TTM)-84.23M
Analysts80
Price Target6.38 (100.94%)
Short Float %22.9%
Short Ratio2.24
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)9.03%
Min EPS beat(2)-15.34%
Max EPS beat(2)33.41%
EPS beat(4)1
Avg EPS beat(4)-4.03%
Min EPS beat(4)-18.3%
Max EPS beat(4)33.41%
EPS beat(8)3
Avg EPS beat(8)-1.42%
EPS beat(12)7
Avg EPS beat(12)3.11%
EPS beat(16)11
Avg EPS beat(16)9.26%
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)-58.94%
EPS NQ rev (1m)-1.18%
EPS NQ rev (3m)27.23%
EPS NY rev (1m)0%
EPS NY rev (3m)37.06%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 2.3
P/tB 2.3
EV/EBITDA N/A
EPS(TTM)-0.93
EYN/A
EPS(NY)-0.69
Fwd EYN/A
FCF(TTM)-0.83
FCFYN/A
OCF(TTM)-0.83
OCFYN/A
SpS0
BVpS1.38
TBVpS1.38
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -60.76%
ROE -65.8%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-45.28%
ROA(5y)-42.37%
ROE(3y)-49.01%
ROE(5y)-50.92%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score6
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 14.18
Quick Ratio 14.18
Altman-Z 11.67
F-Score6
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)23.77%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%0%
EPS Next Y26.39%
EPS Next 2Y13.68%
EPS Next 3Y18.24%
EPS Next 5Y26.81%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-23.17%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-44.95%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-44.95%
OCF growth 3YN/A
OCF growth 5YN/A

REZOLUTE INC / RZLT FAQ

What is the fundamental rating for RZLT stock?

ChartMill assigns a fundamental rating of 3 / 10 to RZLT.


Can you provide the valuation status for REZOLUTE INC?

ChartMill assigns a valuation rating of 0 / 10 to REZOLUTE INC (RZLT). This can be considered as Overvalued.


What is the profitability of RZLT stock?

REZOLUTE INC (RZLT) has a profitability rating of 1 / 10.


What is the earnings growth outlook for REZOLUTE INC?

The Earnings per Share (EPS) of REZOLUTE INC (RZLT) is expected to grow by 26.39% in the next year.


Can you provide the dividend sustainability for RZLT stock?

The dividend rating of REZOLUTE INC (RZLT) is 0 / 10 and the dividend payout ratio is 0%.